Rockland, antibodies-online, and The Jackson Laboratory Partner to Exclusively Offer Innovative Genome Editing Tools to Researchers Worldwide

LIMERICK, Pa .— The Jackson Laboratory (JAX), an independent, nonprofit biomedical research institution dedicated to discovering the genetic and genomic basis of diseases, has entered an exclusivity agreement with Rockland Immunochemicals, Inc. (Rockland) and antibodies-online GmbH (antibodies-online) to provide genomic engineering tools for immuno-oncology research and the development of diagnostics and therapeutics across the globe.

The tool sets will be available for purchase and licensing via Rockland, a leading research reagent manufacturer and custom service provider, and antibodies-online, a go-to destination for research antibodies, ELISA kits, and proteins. A variety of gene editing technologies will be available in these tool sets, including Casilio® and Intres selectable markers developed at JAX.

Casilio® is a CRISPR/dCas9-based enzyme that aids with in situ and in vivo functional studies; and Intres split selectable markers can be utilized in lentiviral transgenesis and CRISPR/Cas-mediated genome editing. Casilio® allows for the study of genes inside living organisms, with the unique ability to simultaneously regulate multiple target genes in a cell. Intres split selectable markers allows for the selection of the right cell population to keep track of these genes as changes are made to them using different methods.

“Over the past few years, we have developed powerful tools for gene editing and control. I am excited that the collaboration of JAX and Rockland will make these tools widely available for researchers worldwide to enable new discoveries and create more impacts in understanding and possibly curing diseases,” said Albert Cheng, the lead inventor.

In this partnership, Rockland brings its manufacturing know-how, quality systems, and technical expertise to support and deliver these novel research tools to scientists across the globe. Leveraging antibody-online’s e-commerce platform and global distribution capabilities, this partnership can achieve the goals of each industry leader — supply critical research reagents to empower the global biomedical community for the advancement of life science.

Jim Fendrick, Rockland’s President and CEO remarked “We are excited about our partnership with JAX. The combined scientific knowledge is incredible, and the vision to make it available to the scientific community to spur scientific discovery is on target.”

Additionally, JAX’s unparalleled mammalian genetics resources and scientific services, as well as its world-class research enterprise focusing on a wide range of diseases including cancer, the microbiome, neurodegenerative diseases, dementia and aging, provide expansive and multidisciplinary technical support to ensure successful implementation for researchers in the scientific community. And, in turn, the market acceptance of these technologies allows for a better understanding of prioritization for current and future technologies developed by each party.

“Casilio and Intres greatly expand the power of CRISPR/Cas-based research tools and provide researchers with important new capabilities for their investigations,” said JAX President and CEO Lon Cardon, Ph.D., FMedSci. “We are pleased to make these important tools, developed through basic research at JAX, available to the global biomedical community.”

Casilio® has issued patents in many countries and has pending applications in several others. JAX has a registered trademark for Casilio® and has filed for Intres, which has multiple pending patents in many countries.

About Rockland Immunochemicals, Inc.
Established in 1962, Rockland is a global biotechnology company manufacturing leading-edge tools for basic, applied, and clinical research for academic, biopharma, diagnostic, and agbio industries. Rockland is a privately held company, operating facilities with antibody and protein production capabilities near Philadelphia, Pennsylvania, USA. Learn more about Rockland at

About antibodies-online GmbH
antibodies-online is a global e-commerce, life science company serving the most exacting scientists and companies to advance scientific achievements important to the health and welfare of people around the world. Since its founding in Aachen, Germany, in 2006, antibodies-online is dedicated to the delivery of the best products available for every demanding project. Learn more about antibodies-online at

About The Jackson Laboratory
The Jackson Laboratory is an independent, nonprofit biomedical research institution with a National Cancer Institute-designated Cancer Center and more than 3,000 employees in locations across the United States, Japan, and China. Its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health. ​​​​​​​For more information, please visit​​​​​​​.

< | >